78 related articles for article (PubMed ID: 9352927)
1. Assembling the glycopeptide antibiotic scaffold: The biosynthesis of A47934 from Streptomyces toyocaensis NRRL15009.
Pootoolal J; Thomas MG; Marshall CG; Neu JM; Hubbard BK; Walsh CT; Wright GD
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8962-7. PubMed ID: 12060705
[TBL] [Abstract][Full Text] [Related]
2. Impact of Bicarbonate-β-Lactam Exposures on Methicillin-Resistant
Ersoy SC; Hanson BM; Proctor RA; Arias CA; Tran TT; Chambers HF; Bayer AS
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828256
[TBL] [Abstract][Full Text] [Related]
3. Proteomic and Membrane Lipid Correlates of Reduced Host Defense Peptide.
Kohler C; Proctor RA; Bayer AS; Yeaman MR; Lalk M; Engelmann S; Mishra NN
Antibiotics (Basel); 2019 Sep; 8(4):. PubMed ID: 31569354
[TBL] [Abstract][Full Text] [Related]
4. Redox Imbalance Underlies the Fitness Defect Associated with Inactivation of the Pta-AckA Pathway in Staphylococcus aureus.
Marshall DD; Sadykov MR; Thomas VC; Bayles KW; Powers R
J Proteome Res; 2016 Apr; 15(4):1205-12. PubMed ID: 26975873
[TBL] [Abstract][Full Text] [Related]
5. The msaABCR operon regulates resistance in vancomycin-intermediate Staphylococcus aureus strains.
Samanta D; Elasri MO
Antimicrob Agents Chemother; 2014 Nov; 58(11):6685-95. PubMed ID: 25155591
[TBL] [Abstract][Full Text] [Related]
6. walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus.
Shoji M; Cui L; Iizuka R; Komoto A; Neoh HM; Watanabe Y; Hishinuma T; Hiramatsu K
Antimicrob Agents Chemother; 2011 Aug; 55(8):3870-81. PubMed ID: 21628539
[TBL] [Abstract][Full Text] [Related]
7. Genetic changes that correlate with the pine-oil disinfectant-reduced susceptibility mechanism of Staphylococcus aureus.
Lamichhane-Khadka R; Riordan JT; Delgado A; Muthaiyan A; Reynolds TD; Wilkinson BJ; Gustafson JE
J Appl Microbiol; 2008 Dec; 105(6):1973-81. PubMed ID: 19120644
[TBL] [Abstract][Full Text] [Related]
8. Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance.
Neoh HM; Cui L; Yuzawa H; Takeuchi F; Matsuo M; Hiramatsu K
Antimicrob Agents Chemother; 2008 Jan; 52(1):45-53. PubMed ID: 17954695
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of staphylococcal biofilm formation by nitrite.
Schlag S; Nerz C; Birkenstock TA; Altenberend F; Götz F
J Bacteriol; 2007 Nov; 189(21):7911-9. PubMed ID: 17720780
[TBL] [Abstract][Full Text] [Related]
10. Transcription Profiling of the mgrA Regulon in Staphylococcus aureus.
Luong TT; Dunman PM; Murphy E; Projan SJ; Lee CY
J Bacteriol; 2006 Mar; 188(5):1899-910. PubMed ID: 16484201
[TBL] [Abstract][Full Text] [Related]
11. Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus.
Cui L; Iwamoto A; Lian JQ; Neoh HM; Maruyama T; Horikawa Y; Hiramatsu K
Antimicrob Agents Chemother; 2006 Feb; 50(2):428-38. PubMed ID: 16436693
[TBL] [Abstract][Full Text] [Related]
12. DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus.
Cui L; Lian JQ; Neoh HM; Reyes E; Hiramatsu K
Antimicrob Agents Chemother; 2005 Aug; 49(8):3404-13. PubMed ID: 16048954
[TBL] [Abstract][Full Text] [Related]
13. Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus.
Nishi H; Komatsuzawa H; Fujiwara T; McCallum N; Sugai M
Antimicrob Agents Chemother; 2004 Dec; 48(12):4800-7. PubMed ID: 15561859
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional induction of the penicillin-binding protein 2 gene in Staphylococcus aureus by cell wall-active antibiotics oxacillin and vancomycin.
Boyle-Vavra S; Yin S; Challapalli M; Daum RS
Antimicrob Agents Chemother; 2003 Mar; 47(3):1028-36. PubMed ID: 12604538
[TBL] [Abstract][Full Text] [Related]
15. Increased glycan chain length distribution and decreased susceptibility to moenomycin in a vancomycin-resistant Staphylococcus aureus mutant.
Komatsuzawa H; Ohta K; Yamada S; Ehlert K; Labischinski H; Kajimura J; Fujiwara T; Sugai M
Antimicrob Agents Chemother; 2002 Jan; 46(1):75-81. PubMed ID: 11751114
[TBL] [Abstract][Full Text] [Related]
16. Activities of trovafloxacin and ampicillin-sulbactam alone or in combination versus three strains of vancomycin- intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model.
Aeschlimann JR; Hershberger E; Rybak MJ
Antimicrob Agents Chemother; 2000 May; 44(5):1153-8. PubMed ID: 10770744
[TBL] [Abstract][Full Text] [Related]
17. Cloning of the Staphylococcus aureus ddh gene encoding NAD+-dependent D-lactate dehydrogenase and insertional inactivation in a glycopeptide-resistant isolate.
Boyle-Vavra S; de Jonge BL; Ebert CC; Daum RS
J Bacteriol; 1997 Nov; 179(21):6756-63. PubMed ID: 9352927
[TBL] [Abstract][Full Text] [Related]
18. Overproduction of a 37-kilodalton cytoplasmic protein homologous to NAD+-linked D-lactate dehydrogenase associated with vancomycin resistance in Staphylococcus aureus.
Milewski WM; Boyle-Vavra S; Moreira B; Ebert CC; Daum RS
Antimicrob Agents Chemother; 1996 Jan; 40(1):166-72. PubMed ID: 8787900
[TBL] [Abstract][Full Text] [Related]
19. Regulation of VanB-type vancomycin resistance gene expression by the VanS(B)-VanR (B) two-component regulatory system in Enterococcus faecalis V583.
Evers S; Courvalin P
J Bacteriol; 1996 Mar; 178(5):1302-9. PubMed ID: 8631706
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
